March, 2017 | The Wall Street Analyzer

Latest News

[ November 22, 2022 ] C-COM OPENS NEW R&D FACILITY FOR ITS PHASED ARRAY ANTENNA DEVELOPMENT News Feed
[ November 16, 2022 ] XORTX Therapeutics Appoints Stacy Evans, M.D., MBA as Chief Business Officer News Feed
[ November 15, 2022 ] Zomedica Announces Third Quarter 2022 Financial Results: $4.78 Million Revenue; 75% Gross Margin & $158.49 Million in Cash News Feed
[ November 9, 2022 ] SCOTTIE RESOURCES EXTENDS STRIKE OF BLUEBERRY CONTACT ZONE TO 1.45 KILOMETERS AND REPORTS INTERCEPT OF 4.24 G/T GOLD OVER 16.95 METRES News Feed
[ November 8, 2022 ] Midnight Sun Drills New High Grade Mineralization at Mitu News Feed
[ November 4, 2022 ] Pro-Dex, Inc. Announces Fiscal 2023 First Quarter Results News Feed
[ November 3, 2022 ] XORTX Announces Participation at Upcoming Investor Conferences News Feed

CanniMed Therapeutics (TSX:CMED) Management Interview

March 30, 2017 The Wall Street Analyzer Comments Off

Interview with John Knowles, CFO […]

Amerigo Announces Filing of NI 43-101 Technical Report

March 30, 2017 The Wall Street Analyzer Comments Off

(TSX:ARG) […]

Vystar Corp (OTC: VYST) CEO: Bill Doyle

March 29, 2017 The Wall Street Analyzer Comments Off

Interview with Bill Doyle, CEO […]

BriaCell Therapeutics (TSXV:BCT)(OTCQB:BCTXF) CEO: Dr. Bill Williams

March 29, 2017 The Wall Street Analyzer Comments Off

Interview with Dr. Bill Williams, CEO and President […]

Citius Pharmaceuticals, Inc. (OTCQB: CTXR) CEO Interview

March 29, 2017 The Wall Street Analyzer Comments Off

Interview with Myron Holubiak, CEO […]

Trovagene, Inc. (NASDAQ: TROV) CEO INTERVIEW

March 28, 2017 The Wall Street Analyzer Comments Off

Interview with Bill Welch, CEO […]

Kratos Defense and Security Solutions (NASDAQ: KTOS) CEO Interview

March 28, 2017 The Wall Street Analyzer Comments Off

Interview with Eric DemArco, CEO and President […]

Prairie Provident Resources (TSX:PPR) CEO Interview

March 27, 2017 The Wall Street Analyzer Comments Off

Interview update with Tim Granger, CEO […]

Pro-Dex Inc (NASDAQ: PDEX) CEO Interview

March 23, 2017 The Wall Street Analyzer Comments Off

Interview with CEO Rick Van Kirk […]

Vuzix Corp (NASDAQ: VUZI) CEO Interview

March 23, 2017 The Wall Street Analyzer Comments Off

Interview with Paul Travers, CEO […]

Featured Interviews

Zerify (OTCQB: ZRFY)

November 17, 2022 0

ABOUT: Zerify Inc. (OTCQB: ZRFY), formerly StrikeForce Technologies, is an Edison, New Jersey-based company with over two decades of experience in cybersecurity solutions. The company helps to prevent cyber theft and data security breaches for […]

CEO Interviews

C-COM Satellite Systems Inc. (TSXV: CMI) (OTCQB: CYSNF)

November 4, 2022 0

ABOUT: C-COM Satellite Systems Inc. is a pioneer and world leader in the design, development, and manufacture of transportable and mobile satellite-based antenna systems. The Company has sold more than 10,000 antenna systems, in over […]

Featured Interviews

Xortx Therapeutics (CSE: XRX) (NASDAQ: XRTF)

October 25, 2022 0

ABOUT: XORTX is a pharmaceutical company with two clinically advanced products in development: 1) our lead program in XRx-008 for ADPKD; and 2) our secondary program in XRx-101 for acute kidney and other acute organ […]

CEO Interviews

Scottie Resources (TSXV: SCOT)(OTCQB: SCTSF) Brad Rourke, CEO and President

October 24, 2022 0

INTERVIEW TRANSCRIPTS: WSA: Good day from Wall Street. This is Juan Costello, Senior Analyst with The Wall Street Analyzer. Joining us today is Brad Rourke, CEO and President at Scottie Resources. The company trades on […]

CEO Interviews

Pro-Dex, Inc (NASDAQ: PDEX) CEO Interview Update

October 24, 2022 0

ABOUT: Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used […]

Month: March 2017

CanniMed Therapeutics (TSX:CMED) Management Interview

Amerigo Announces Filing of NI 43-101 Technical Report

Vystar Corp (OTC: VYST) CEO: Bill Doyle

BriaCell Therapeutics (TSXV:BCT)(OTCQB:BCTXF) CEO: Dr. Bill Williams

Citius Pharmaceuticals, Inc. (OTCQB: CTXR) CEO Interview

Trovagene, Inc. (NASDAQ: TROV) CEO INTERVIEW

Kratos Defense and Security Solutions (NASDAQ: KTOS) CEO Interview

Prairie Provident Resources (TSX:PPR) CEO Interview

Pro-Dex Inc (NASDAQ: PDEX) CEO Interview

Vuzix Corp (NASDAQ: VUZI) CEO Interview

Co-Diagnostics (NASDAQ: CODX) is Well-positioned with 3 Key Verticals

Client Testimonials: